Dr. Stephenson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
330 Brookline Ave
Boston, MA 02215
Education & Training
New York University School of MedicineClass of 2005
Certifications & Licensure
MA State Medical License 2010 - 2025
NY State Medical License 2007 - 2009- American Board of Internal Medicine Infectious Disease
Clinical Trials
- Clinical Trial to Evaluate the Safety and Immunogenicity of Ferritin Nanoparticles Expressing Native-like HIV-1 Envelope Trimers Followed by Boost With mRNA Lipid Nanoparticles Encoding a Native-like HIV-1 Envelope Trimer in Adults Without HIV Start of enrollment: 2023 Aug 29
Roles: Contact
- The Study of Immunization in People Living With HIV Undergoing an ATI for Elicitation of VRC01-lineage Antibodies Start of enrollment: 2024 Jan 03
Roles: Contact
- General Pre-Trial Screening Protocol for Infectious Diseases Research Start of enrollment: 2024 Jun 01
Roles: Principal Investigator, Contact
Publications & Presentations
PubMed
- 776 citationsInterim Results of a Phase 1-2a Trial of Ad26.COV2.S Covid-19 Vaccine.Jerald C. Sadoff, Mathieu Le Gars, Georgi Shukarev, Dirk Heerwegh, Carla Truyers
The New England Journal of Medicine. 2021-01-13 - 214 citationsImmunogenicity of the Ad26.COV2.S Vaccine for COVID-19.Kathryn E. Stephenson, Mathieu Le Gars, Jerald C. Sadoff, Anne Marit de Groot, Dirk Heerwegh
JAMA. 2021-04-20 - 73 citationsCompassionate Use of Remdesivir in Pregnant Women with Severe Covid-19.Richard M. Burwick, Sigal Yawetz, Kathryn E. Stephenson, Ai-ris Y. Collier, Pritha Sen
Clinical Infectious Diseases. 2020-10-08
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
